The endocannabinoid, anandamide, augments notch-1 signaling in cultured cortical neurons exposed to amyloid- β and in the cortex of aged rats

Riffat Tanveer, Aoife Gowran, Janis Noonan, Sinead E. Keating, Andrew G. Bowie, Veronica A. Campbell

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Aberrant Notch signaling has recently emerged as a possible mechanism for the altered neurogenesis, cognitive impairment, and learning and memory deficits associated with Alzheimer disease (AD). Recently, targeting the endocannabinoid system in models of AD has emerged as a potential approach to slow the progression of the disease process. Although studies have identified neuroprotective roles for endocannabinoids, there is a paucity of information on modulation of the pro-survival Notch pathway by endocannabinoids. In this study the influence of the endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol, on the Notch-1 pathway and on its endogenous regulators were investigated in an in vitro model of AD. We report that AEA up-regulates Notch-1 signaling in cultured neurons. We also provide evidence that although Aβ1-42 increases expression of the endogenous inhibitor of Notch-1, numb (Nb), this can be prevented by AEA and 2-arachidonoylglycerol. Interestingly, AEA up-regulated Nct expression, a component of γ-secretase, and this was found to play a crucial role in the enhanced Notch-1 signaling mediated by AEA. The stimulatory effects of AEA on Notch-1 signaling persisted in the presence of Aβ1-42. AEA was found to induce a preferential processing of Notch-1 over amyloid precursor protein to generate Aβ1-40. Aging, a natural process of neurodegeneration, was associated with a reduction in Notch-1 signaling in rat cortex and hippocampus, and this was restored with chronic treatment with URB 597. In summary, AEA has the proclivity to enhance Notch-1 signaling in an in vitro model of AD, which may have relevance for restoring neurogenesis and cognition in AD.

Original languageEnglish
Pages (from-to)34709-34721
Number of pages13
JournalJournal of Biological Chemistry
Volume287
Issue number41
DOIs
Publication statusPublished - Oct 5 2012

Fingerprint

Endocannabinoids
Amyloid
Neurons
Rats
Alzheimer Disease
Neurogenesis
Amyloid Precursor Protein Secretases
Amyloid beta-Protein Precursor
Memory Disorders
Cognition
Disease Progression
Hippocampus
Up-Regulation
anandamide
Learning
Aging of materials
Modulation
Data storage equipment
Processing

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

The endocannabinoid, anandamide, augments notch-1 signaling in cultured cortical neurons exposed to amyloid- β and in the cortex of aged rats. / Tanveer, Riffat; Gowran, Aoife; Noonan, Janis; Keating, Sinead E.; Bowie, Andrew G.; Campbell, Veronica A.

In: Journal of Biological Chemistry, Vol. 287, No. 41, 05.10.2012, p. 34709-34721.

Research output: Contribution to journalArticle

Tanveer, Riffat ; Gowran, Aoife ; Noonan, Janis ; Keating, Sinead E. ; Bowie, Andrew G. ; Campbell, Veronica A. / The endocannabinoid, anandamide, augments notch-1 signaling in cultured cortical neurons exposed to amyloid- β and in the cortex of aged rats. In: Journal of Biological Chemistry. 2012 ; Vol. 287, No. 41. pp. 34709-34721.
@article{945239cd388140ee8296f32abba5f886,
title = "The endocannabinoid, anandamide, augments notch-1 signaling in cultured cortical neurons exposed to amyloid- β and in the cortex of aged rats",
abstract = "Aberrant Notch signaling has recently emerged as a possible mechanism for the altered neurogenesis, cognitive impairment, and learning and memory deficits associated with Alzheimer disease (AD). Recently, targeting the endocannabinoid system in models of AD has emerged as a potential approach to slow the progression of the disease process. Although studies have identified neuroprotective roles for endocannabinoids, there is a paucity of information on modulation of the pro-survival Notch pathway by endocannabinoids. In this study the influence of the endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol, on the Notch-1 pathway and on its endogenous regulators were investigated in an in vitro model of AD. We report that AEA up-regulates Notch-1 signaling in cultured neurons. We also provide evidence that although Aβ1-42 increases expression of the endogenous inhibitor of Notch-1, numb (Nb), this can be prevented by AEA and 2-arachidonoylglycerol. Interestingly, AEA up-regulated Nct expression, a component of γ-secretase, and this was found to play a crucial role in the enhanced Notch-1 signaling mediated by AEA. The stimulatory effects of AEA on Notch-1 signaling persisted in the presence of Aβ1-42. AEA was found to induce a preferential processing of Notch-1 over amyloid precursor protein to generate Aβ1-40. Aging, a natural process of neurodegeneration, was associated with a reduction in Notch-1 signaling in rat cortex and hippocampus, and this was restored with chronic treatment with URB 597. In summary, AEA has the proclivity to enhance Notch-1 signaling in an in vitro model of AD, which may have relevance for restoring neurogenesis and cognition in AD.",
author = "Riffat Tanveer and Aoife Gowran and Janis Noonan and Keating, {Sinead E.} and Bowie, {Andrew G.} and Campbell, {Veronica A.}",
year = "2012",
month = "10",
day = "5",
doi = "10.1074/jbc.M112.350678",
language = "English",
volume = "287",
pages = "34709--34721",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "41",

}

TY - JOUR

T1 - The endocannabinoid, anandamide, augments notch-1 signaling in cultured cortical neurons exposed to amyloid- β and in the cortex of aged rats

AU - Tanveer, Riffat

AU - Gowran, Aoife

AU - Noonan, Janis

AU - Keating, Sinead E.

AU - Bowie, Andrew G.

AU - Campbell, Veronica A.

PY - 2012/10/5

Y1 - 2012/10/5

N2 - Aberrant Notch signaling has recently emerged as a possible mechanism for the altered neurogenesis, cognitive impairment, and learning and memory deficits associated with Alzheimer disease (AD). Recently, targeting the endocannabinoid system in models of AD has emerged as a potential approach to slow the progression of the disease process. Although studies have identified neuroprotective roles for endocannabinoids, there is a paucity of information on modulation of the pro-survival Notch pathway by endocannabinoids. In this study the influence of the endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol, on the Notch-1 pathway and on its endogenous regulators were investigated in an in vitro model of AD. We report that AEA up-regulates Notch-1 signaling in cultured neurons. We also provide evidence that although Aβ1-42 increases expression of the endogenous inhibitor of Notch-1, numb (Nb), this can be prevented by AEA and 2-arachidonoylglycerol. Interestingly, AEA up-regulated Nct expression, a component of γ-secretase, and this was found to play a crucial role in the enhanced Notch-1 signaling mediated by AEA. The stimulatory effects of AEA on Notch-1 signaling persisted in the presence of Aβ1-42. AEA was found to induce a preferential processing of Notch-1 over amyloid precursor protein to generate Aβ1-40. Aging, a natural process of neurodegeneration, was associated with a reduction in Notch-1 signaling in rat cortex and hippocampus, and this was restored with chronic treatment with URB 597. In summary, AEA has the proclivity to enhance Notch-1 signaling in an in vitro model of AD, which may have relevance for restoring neurogenesis and cognition in AD.

AB - Aberrant Notch signaling has recently emerged as a possible mechanism for the altered neurogenesis, cognitive impairment, and learning and memory deficits associated with Alzheimer disease (AD). Recently, targeting the endocannabinoid system in models of AD has emerged as a potential approach to slow the progression of the disease process. Although studies have identified neuroprotective roles for endocannabinoids, there is a paucity of information on modulation of the pro-survival Notch pathway by endocannabinoids. In this study the influence of the endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol, on the Notch-1 pathway and on its endogenous regulators were investigated in an in vitro model of AD. We report that AEA up-regulates Notch-1 signaling in cultured neurons. We also provide evidence that although Aβ1-42 increases expression of the endogenous inhibitor of Notch-1, numb (Nb), this can be prevented by AEA and 2-arachidonoylglycerol. Interestingly, AEA up-regulated Nct expression, a component of γ-secretase, and this was found to play a crucial role in the enhanced Notch-1 signaling mediated by AEA. The stimulatory effects of AEA on Notch-1 signaling persisted in the presence of Aβ1-42. AEA was found to induce a preferential processing of Notch-1 over amyloid precursor protein to generate Aβ1-40. Aging, a natural process of neurodegeneration, was associated with a reduction in Notch-1 signaling in rat cortex and hippocampus, and this was restored with chronic treatment with URB 597. In summary, AEA has the proclivity to enhance Notch-1 signaling in an in vitro model of AD, which may have relevance for restoring neurogenesis and cognition in AD.

UR - http://www.scopus.com/inward/record.url?scp=84867257671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867257671&partnerID=8YFLogxK

U2 - 10.1074/jbc.M112.350678

DO - 10.1074/jbc.M112.350678

M3 - Article

VL - 287

SP - 34709

EP - 34721

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 41

ER -